Connetics Corp. has agreed to acquire exclusive U.S. rights to Roche Holding AG's Soriatane (acitretin).
Phase 3 Trial Data Highlights Efficacy of OnabotulinutoxinA in Platysma Prominence
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
POLL: What Strategies Have You Found Most Effective in Managing Alopecia?
The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice
Hyaluronic Acid-Based Fillers Effective in Treating Signs of Aging
Pointers With Portela: What to Know About Ozempic
2 Clarke Drive Cranbury, NJ 08512